RNA, U7 small nuclear 123 pseudogeneGenealiases: []
Q-omics provides the consensus-scored RNU7-123P profile across patient tissues and cancer cell-line models. RNU7-123P expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, RNU7-123P is differentially expressed in 9, with the highest sampling consensus in BLCA. Additionally, RNU7-123P RNA expression shows 15,717 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight ACC, BLCA, and UVM as cancer lineages where RNU7-123P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RNU7-123P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RNU7-123P survival associations across molecular data types. RNU7-123P RNA expression shows survival associations in the most cancer types (23). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RNU7-123P RNA expression–survival associations across cancer types. High RNU7-123P expression shows unfavorable associations in ACC, LIHC, LGG and OV, but favorable associations in SKCM and LUAD. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .002). Together, the overview and detailed table identify ACC as the clearest survival context for RNU7-123P RNA expression.
This table summarizes RNU7-123P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 9. The strongest signals are observed in BLCA for RNA.
This table ranks reproducible tumor–normal expression differences for RNU7-123P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RNU7-123P shows lower tumor expression in LUAD and KIRP and higher tumor expression in BLCA, CHOL, LIHC and STAD. The BLCA box plot shows higher RNU7-123P RNA expression in tumor versus normal tissue (log2 FC = +1.175, t-test p < 0.001).
This table shows molecular features associated with RNU7-123P in patient tissues and cancer cell lines. In patient samples, RNU7-123P shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
